Literature DB >> 19381953

Tissue microarrays as a tool in the discovery and validation of tumor markers.

Stephen M Hewitt1.   

Abstract

Tissue microarrays are a platform of condensed histopathology that has revolutionized the translation of basic science to clinical utility. Tissue microarrays have resulted in a paradigm shift from histopathology to immunopathology and moved analysis of small selected samples sets of tens of specimens to a high-throughput environment of hundreds of specimens. Tissue microarrays have influenced validation strategies, but have a role in discovery as well, allowing a pathways approach to analysis of tumors.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19381953      PMCID： PMC7297263          DOI： 10.1007/978-1-60327-811-9_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  19 in total

1.  Evaluation of non-formalin tissue fixation for molecular profiling studies.

Authors:  John W Gillespie; Carolyn J M Best; Verena E Bichsel; Kristina A Cole; Susan F Greenhut; Stephen M Hewitt; Mamoun Ahram; Yvonne B Gathright; Maria J Merino; Robert L Strausberg; Jonathan I Epstein; Stanley R Hamilton; Gallya Gannot; Galina V Baibakova; Valerie S Calvert; Michael J Flaig; Rodrigo F Chuaqui; Judi C Herring; John Pfeifer; Emmanuel F Petricoin; W Marston Linehan; Paul H Duray; G Steven Bova; Michael R Emmert-Buck
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 2.  Post-analysis follow-up and validation of microarray experiments.

Authors:  Rodrigo F Chuaqui; Robert F Bonner; Carolyn J M Best; John W Gillespie; Michael J Flaig; Stephen M Hewitt; John L Phillips; David B Krizman; Michael A Tangrea; Mamoun Ahram; W Marston Linehan; Vladimir Knezevic; Michael R Emmert-Buck
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

3.  Design, construction, and use of tissue microarrays.

Authors:  Stephen M Hewitt
Journal:  Methods Mol Biol       Date:  2004

Review 4.  The application of tissue microarrays in the validation of microarray results.

Authors:  Stephen M Hewitt
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 5.  Tissue microarrays enabling high-throughput molecular pathology.

Authors:  Mikiko Takikita; Joon-Yong Chung; Stephen M Hewitt
Journal:  Curr Opin Biotechnol       Date:  2007-07-20       Impact factor: 9.740

6.  Tissues from population-based cancer registries: a novel approach to increasing research potential.

Authors:  Marc T Goodman; Brenda Y Hernandez; Stephen Hewitt; Charles F Lynch; Timothy R Coté; Henry F Frierson; Christopher A Moskaluk; Jeffrey L Killeen; Wendy Cozen; Charles R Key; Limin Clegg; Marsha Reichman; Benjamin F Hankey; Brenda Edwards
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

7.  Proteomic expression profiling of thyroid neoplasms.

Authors:  Till Braunschweig; Klaus Kaserer; Joon-Yong Chung; Sven Bilke; David Krizman; Vladimir Knezevic; Stephen M Hewitt
Journal:  Proteomics Clin Appl       Date:  2007-03       Impact factor: 3.494

8.  NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes.

Authors:  Miklós Geiszt; Kristen Lekstrom; Sebastian Brenner; Stephen M Hewitt; Raya Dana; Harry L Malech; Thomas L Leto
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

10.  A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.

Authors:  Huai-En Huang; Suet-Feung Chin; Christophe Ginestier; Valérie-Jeanne Bardou; José Adélaïde; N Gopalakrishna Iyer; Maria J Garcia; Jessica C Pole; Grace M Callagy; Stephen M Hewitt; William J Gullick; Jocelyne Jacquemier; Carlos Caldas; Max Chaffanet; Daniel Birnbaum; Paul A W Edwards
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701
View more
  6 in total

Review 1.  Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer.

Authors:  James F Rusling; Challa V Kumar; J Silvio Gutkind; Vyomesh Patel
Journal:  Analyst       Date:  2010-07-08       Impact factor: 4.616

2.  Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues.

Authors:  Satori A Marchitti; David J Orlicky; Chad Brocker; Vasilis Vasiliou
Journal:  J Histochem Cytochem       Date:  2010-09       Impact factor: 2.479

Review 3.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

4.  Cancer proteomics--an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine.

Authors:  Ben C Collins; Thomas Y K Lau; Darran P O'Connor; Hubert Hondermarck
Journal:  EMBO Rep       Date:  2009-10-02       Impact factor: 8.807

5.  Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.

Authors:  David L Rimm; Torsten O Nielsen; Scott D Jewell; Daniel C Rohrer; Gloria Broadwater; Frederic Waldman; Kisha A Mitchell; Baljit Singh; Gregory J Tsongalis; Wendy L Frankel; Anthony M Magliocco; Jonathan F Lara; Eric D Hsi; Ira J Bleiweiss; Sunil S Badve; Beiyun Chen; Peter M Ravdin; Richard L Schilsky; Ann Thor; Donald A Berry
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

6.  Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen.

Authors:  Michael Babich; Ankit Sharma; Tianhong Li; James A Radosevich
Journal:  Heliyon       Date:  2022-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.